Novartis AG Moves Closer to First Oral MS Treatment

Reuters -- Swiss drugmaker Novartis AG edged closer to bringing the first oral multiple sclerosis treatment to market after new data showed its Gilenia cut relapse rates in the disease on Tuesday.